Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparative Study

Michał Chalcarz; Beniamin Oskar Grabarek; Mateusz de Mezer; Piotr Krokowicz; Janusz Patera; Krzysztof Czupryna; Jakub Żurawski

doi:10.12659/MSM.942882

20 March 2024 : Clinical Research

Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparative Study

Michał Chalcarz

^1ABCDE*, Beniamin Oskar Grabarek

^2EF, Mateusz de Mezer

^3E, Piotr Krokowicz^4BE, Janusz Patera^5F, Krzysztof Czupryna

^2F, Jakub Żurawski

^6AEF

DOI: 10.12659/MSM.942882

Med Sci Monit 2024; 30:e942882

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Percentage of patients in the colorectal cancer patients group and the comparison groups with selenium levels that were within normal, below normal, or above normal range.

Back to the Article

Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparative Study

Your Privacy